...
首页> 外文期刊>Scientific reports. >Identification of novel PKD1 and PKD2 mutations in a Chinese population with autosomal dominant polycystic kidney disease
【24h】

Identification of novel PKD1 and PKD2 mutations in a Chinese population with autosomal dominant polycystic kidney disease

机译:中国常染色体显性遗传性多囊肾患者中 PKD1 和 PKD2 突变的鉴定

获取原文
           

摘要

Autosomal dominant polycystic kidney disease (ADPKD) is one of the most frequently inherited renal diseases caused by mutations in PKD1 and PKD2 . We performed mutational analyses of PKD genes in 49 unrelated patients using direct PCR-sequencing and multiplex ligation-dependent probe amplification (MLPA) for PKD1 and PKD2 . RT-PCR analysis was also performed in a family with a novel PKD2 splicing mutation. Disease-causing mutations were identified in 44 (89.8%) of the patients: 42 (95.5%) of the patients showed mutations in PKD1 , and 2 (4.5%) showed mutations in PKD2 . Ten nonsense, 17 frameshift, 4 splicing and one in-frame mutation were found in 32 of the patients. Large rearrangements were found in 3 patients, and missense mutations were found in 9 patients. Approximately 61.4% (27/44) of the mutations are first reported with a known mutation rate of 38.6%. RNA analysis of a novel PKD2 mutation (c.595_595?+?14delGGTAAGAGCGCGCGA) suggested monoallelic expression of the wild-type allele. Furthermore, patients with PKD1 -truncating mutations reached end-stage renal disease (ESRD) earlier than patients with non-truncating mutations (47?±?3.522 years vs. 59?±?11.687 years, P =?0.016). The mutation screening of PKD genes in Chinese ADPKD patients will enrich our mutation database and significantly contribute to improve genetic counselling for ADPKD patients.
机译:常染色体显性遗传性多囊肾疾病(ADPKD)是由PKD1和PKD2突变引起的最常见的遗传性肾脏疾病之一。我们使用直接PCR测序和多重连接依赖探针扩增(MLPA)对PKD1和PKD2进行了49位无关患者的PKD基因突变分析。在具有新型PKD2剪接突变的家族中也进行了RT-PCR分析。在44例患者中发现了致病突变(89.8%):42例(95.5%)患者显示PKD1突变,2例(4.5%)显示PKD2突变。在32例患者中发现10个废话,17个移码,4个剪接和1个符合读框的突变。 3例患者发现较大的重排,9例患者发现错义突变。首先报道了约61.4%(27/44)的突变,已知突变率为38.6%。新的PKD2突变(c.595_595?+?14delGGTAAGAGCGCGCGA)的RNA分析表明野生型等位基因的单等位基因表达。此外,具有PKD1截短突变的患者比非截短突变的患者更早到达终末期肾脏疾病(ESRD)(47?±?3.522岁vs. 59?±?11.687岁,P =?0.016)。中国ADPKD患者PKD基因的突变筛选将丰富我们的突变数据库,并显着有助于改善ADPKD患者的遗传咨询。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号